Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Breast 4Thoracic 2Other 2Gastrointestinal 2Tumor-Agnostic 1Lymphoid 1Head & Neck 1Gynecologic 1Endocrine 1

Conditions

Colonic Neoplasms 2

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 328Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 257lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anti-Inflammatory Agents, Non-Steroidal × Gastrointestinal × Clear all
NCT03974984 2020-11-05

ANIMOX

University of Copenhagen

Withdrawn
Gastrointestinal

Colonic Neoplasms

NCT04448652 2020-06-26

Does Omission of NSAIDs After Colorectal Cancer Operation Affect the Consumption of Opioids?

Zealand University Hospital

Completed
502 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡